Cargando…
Effect of Flumazenil on Hypoactive Delirium in the ICU: A Double-Blind, Placebo-Controlled Pilot Study
To determine whether the use of flumazenil reverses hypoactive delirium and increases delirium-free days in critically ill patients who were exposed to benzodiazepine therapy during the ICU admission. DESIGN: This was a single-center, double-blinded, randomized placebo-controlled pilot study. SETTIN...
Autores principales: | Schomer, Kendra J., Duby, Jeremiah J., Firestone, Rachelle L., Louie, Erin L., Sebat, Christian M., Love, Dawn M., Cocanour, Christine S., Albertson, Timothy E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098541/ https://www.ncbi.nlm.nih.gov/pubmed/32259108 http://dx.doi.org/10.1097/CCE.0000000000000085 |
Ejemplares similares
-
Investigation into detection and treatment rates of hyperactive and hypoactive delirium in the ICU setting
por: Kudsk-Iversen, S, et al.
Publicado: (2012) -
Recent Insights on Prevalence and Corelations of Hypoactive Delirium
por: Peritogiannis, Vaios, et al.
Publicado: (2015) -
Pharmacological treatment of hypoactive delirium in critically ill patients: a systematic review
por: Carvalho, JPLM, et al.
Publicado: (2013) -
Erratum: A Note on Common Apathy versus Hypoactive Delirium in Critical Illness
Publicado: (2021) -
Study protocol for a prospective randomised double-blind placebo-controlled clinical trial investigating a Better Outcome with Melatonin compared to Placebo Administered to normalize sleep–wake cycle and treat hypoactive ICU Delirium: the Basel BOMP-AID study
por: Hollinger, Alexa, et al.
Publicado: (2020)